TY - JOUR AU - Bushby, K. AU - Finkel, R. AU - Birnkrant, D. J. AU - Case, L. E. AU - Clemens, P. R. AU - Cripe, L. PY - 2010 DA - 2010// TI - Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management JO - Lancet Neurol VL - 9 UR - https://doi.org/10.1016/S1474-4422(09)70271-6 DO - 10.1016/S1474-4422(09)70271-6 ID - Bushby2010 ER - TY - STD TI - US Food and Drug Administration. EXONDYS 51 full prescribing information 2016. doi. http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf. Accessed 17 Mar 2017. UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf ID - ref2 ER - TY - STD TI - McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F0, Osorio AN, Schara U, Sejersen T, Shieh PB, Sweeney HL, Topaloglu H, Tulinius M, Vilchez JJ, Voit T, Wong B, Elfring G, Kroger H, Luo X, McIntosh J, Ong T, Riebling P, Souza M, Spiegel RJ, Peltz SW, Mercuri E; Alfano LN, Eagle M, James MK, Lowes L, Mayhew A, Mazzone ES, Nelson L, Rose KJ, Abdel-Hamid HZ, Apkon SD, Barohn RJ, Bertini E, Bloetzer C, de Vaud LC, Butterfield RJ, Chabrol B, Chae JH, Jongno-Gu DR, Comi GP, Darras BT, Dastgir J, Desguerre I, Escobar RG, Finanger E, Guglieri M, Hughes I, Iannaccone ST, Jones KJ, Karachunski P, Kudr M, Lotze T, Mah JK, Mathews K, Nevo Y, Parsons J, Péréon Y, de Queiroz Campos Araujo AP, Renfroe JB, de Resende MBD, Ryan M, Selby K, Tennekoon G, Vita G. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10101):1489–498. ID - ref3 ER - TY - STD TI - Sarepta Therapeutics. Clinical trials: the basics and our clinical trials: a double-blind, placebo-controlled, multi-center study with an open-label extension to evaluate the efficacy and safety of SRP-4045 and SRP-4053 in patients with Duchenne muscular dystrophy 2017;2017. ID - ref4 ER - TY - STD TI - ClinicalTrials.gov. Registry of Translarna (Ataluren) in nonsense mutation Duchenne muscular dystrophy: NCT02369731. 2017. doi. https://clinicaltrials.gov/ct2/show/NCT02369731. Accessed 17 Mar 2017. UR - https://clinicaltrials.gov/ct2/show/NCT02369731 ID - ref5 ER - TY - STD TI - ClinicalTrials.gov. Confirmatory study of eteplirsen in DMD patients (PROMOVI): NCT02255552. 2017. doi. https://clinicaltrials.gov/ct2/show/NCT02255552. Accessed 17 Mar 2017. UR - https://clinicaltrials.gov/ct2/show/NCT02255552 ID - ref6 ER - TY - JOUR AU - Finkel, R. S. AU - Flanigan, K. M. AU - Wong, B. AU - Bonnemann, C. AU - Sampson, J. AU - Sweeney, H. L. PY - 2013 DA - 2013// TI - Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0081302 DO - 10.1371/journal.pone.0081302 ID - Finkel2013 ER - TY - STD TI - Kole R, Krieg AM. Exon skipping therapy for Duchenne muscular dystrophy. Adv Drug Deliv Rev. 2015;87:104–7. ID - ref8 ER - TY - STD TI - McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387(6682):83–90. ID - ref9 ER - TY - STD TI - Lee SJ. Regulation of muscle mass by myostatin. Ann Rev Cell Dev Biol. 2004:2061–86. ID - ref10 ER - TY - JOUR AU - Joulia-Ekaza, D. AU - Cabello, G. PY - 2006 DA - 2006// TI - Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects JO - Exp Cell Res VL - 312 UR - https://doi.org/10.1016/j.yexcr.2006.04.012 DO - 10.1016/j.yexcr.2006.04.012 ID - Joulia-Ekaza2006 ER - TY - JOUR AU - Mosher, D. S. AU - Quignon, P. AU - Bustamante, C. D. AU - Sutter, N. B. AU - Mellersh, C. S. AU - Parker, H. G. PY - 2007 DA - 2007// TI - A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs JO - PLoS Genet VL - 3 UR - https://doi.org/10.1371/journal.pgen.0030079 DO - 10.1371/journal.pgen.0030079 ID - Mosher2007 ER - TY - JOUR AU - Elkina, Y. AU - von Haehling, S. AU - Anker, S. D. AU - Springer, J. PY - 2011 DA - 2011// TI - The role of myostatin in muscle wasting: an overview JO - J Cachexia Sarcopenia Muscle VL - 2 UR - https://doi.org/10.1007/s13539-011-0035-5 DO - 10.1007/s13539-011-0035-5 ID - Elkina2011 ER - TY - JOUR AU - Bulfield, G. AU - Siller, W. G. AU - Wight, P. A. AU - Moore, K. J. X. PY - 1984 DA - 1984// TI - Chromosome-linked muscular dystrophy (mdx) in the mouse JO - Proc Natl Acad Sci U S A VL - 81 UR - https://doi.org/10.1073/pnas.81.4.1189 DO - 10.1073/pnas.81.4.1189 ID - Bulfield1984 ER - TY - JOUR AU - Bogdanovich, S. AU - Barton, E. R. AU - Morris, L. D. AU - Whittemore, L. A. AU - Ahima, R. S. PY - 2002 DA - 2002// TI - Functional improvement of dystrophic muscle by myostatin blockade JO - Nature VL - 420 UR - https://doi.org/10.1038/nature01154 DO - 10.1038/nature01154 ID - Bogdanovich2002 ER - TY - JOUR AU - Bogdanovich, S. AU - Perkins, K. J. AU - Whittemore, L. A. AU - Khurana, T. S. PY - 2005 DA - 2005// TI - Myostatin propeptide-mediated amelioration of dystrophic pathophysiology JO - FASEB J VL - 19 UR - https://doi.org/10.1096/fj.04-2796com DO - 10.1096/fj.04-2796com ID - Bogdanovich2005 ER - TY - JOUR AU - Whittemore, L. A. AU - Song, K. AU - Li, X. AU - Aghajanian, J. AU - Davies, M. AU - Girgenrath, S. PY - 2003 DA - 2003// TI - Inhibition of myostatin in adult mice increases skeletal muscle mass and strength JO - Biochem Biophys Res Commun VL - 300 UR - https://doi.org/10.1016/S0006-291X(02)02953-4 DO - 10.1016/S0006-291X(02)02953-4 ID - Whittemore2003 ER - TY - JOUR AU - Pistilli, E. E. AU - Bogdanovich, S. AU - Goncalves, M. D. AU - Ahima, R. S. AU - Lachey, J. AU - Seehra, J. PY - 2011 DA - 2011// TI - Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy JO - Am J Pathol VL - 178 UR - https://doi.org/10.1016/j.ajpath.2010.11.071 DO - 10.1016/j.ajpath.2010.11.071 ID - Pistilli2011 ER - TY - STD TI - Kemaladewi DU, Hoogaars WM, van Heiningen SH, Terlouw S, de Gorter DJ, den Dunnen JT, et al. Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy. BMC Med Genet. 2011;4:36. ID - ref19 ER - TY - STD TI - Malerba A, Kang JK, McClorey G, Saleh AF, Popplewell L, Gait MJ, et al. Dual myostatin and dystrophin exon skipping by morpholino nucleic acid oligomers conjugated to a cell-penetrating peptide is a promising therapeutic strategy for the treatment of Duchenne muscular dystrophy. Mol Ther Nucleic Acids. 2012;(12)e62. ID - ref20 ER - TY - JOUR AU - Apgar, J. R. AU - Mader, M. AU - Agostinelli, R. AU - Benard, S. AU - Bialek, P. AU - Johnson, M. PY - 2016 DA - 2016// TI - Beyond CDR-grafting: structure-guided humanization of framework and CDR regions of an anti-myostatin antibody JO - MAbs VL - 8 UR - https://doi.org/10.1080/19420862.2016.1215786 DO - 10.1080/19420862.2016.1215786 ID - Apgar2016 ER - TY - JOUR AU - Holzbaur, E. L. AU - Howland, D. S. AU - Weber, N. AU - Wallace, K. AU - She, Y. AU - Kwak, S. PY - 2006 DA - 2006// TI - Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis JO - Neurobiol Dis VL - 23 UR - https://doi.org/10.1016/j.nbd.2006.05.009 DO - 10.1016/j.nbd.2006.05.009 ID - Holzbaur2006 ER - TY - JOUR AU - Thies, R. S. AU - Chen, T. AU - Davies, M. V. AU - Tomkinson, K. N. AU - Pearson, A. A. AU - Shakey, Q. A. PY - 2001 DA - 2001// TI - GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding JO - Growth Factors VL - 18 UR - https://doi.org/10.3109/08977190109029114 DO - 10.3109/08977190109029114 ID - Thies2001 ER - TY - JOUR AU - Lee, S. J. AU - Reed, L. A. AU - Davies, M. V. AU - Girgenrath, S. AU - Goad, M. E. AU - Tomkinson, K. N. PY - 2005 DA - 2005// TI - Regulation of muscle growth by multiple ligands signaling through activin type II receptors JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0505996102 DO - 10.1073/pnas.0505996102 ID - Lee2005 ER - TY - JOUR AU - Korchynskyi, O. AU - ten Dijke, P. PY - 2002 DA - 2002// TI - Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M111023200 DO - 10.1074/jbc.M111023200 ID - Korchynskyi2002 ER - TY - STD TI - Brooks SV, Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol. 1988;404:71–82. ID - ref26 ER - TY - STD TI - Lakshman KM, Bhasin S, Corcoran C, Collins-Racie LA, Tchistiakova L, Forlow SB, et al. Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration. Mol Cell Endocrinol. 2009;302(1):26–32. ID - ref27 ER - TY - STD TI - Smith RC, Lin BK. Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders. Curr Opin Support Palliat Care. 2013;(4):352–60. ID - ref28 ER - TY - STD TI - Campbell C, McMillian HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, et al. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial. Muscle Nerve. 2016; https://doi.org/10.1002/mus.25268. ID - ref29 ER - TY - JOUR AU - Wagner, K. R. AU - Fleckenstein, J. L. AU - Amato, A. A. AU - Barohn, R. J. AU - Bushby, K. AU - Escolar, D. M. PY - 2008 DA - 2008// TI - A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy JO - Ann Neurol VL - 63 UR - https://doi.org/10.1002/ana.21338 DO - 10.1002/ana.21338 ID - Wagner2008 ER - TY - JOUR AU - Singh, P. AU - Rong, H. AU - Gordi, T. AU - Bosley, J. AU - Bhattacharya, I. PY - 2016 DA - 2016// TI - Translational pharmacokinetic/pharmacodynamic analysis of MYO-029 antibody for muscular dystrophy JO - Clin Transl Sci VL - 9 UR - https://doi.org/10.1111/cts.12420 DO - 10.1111/cts.12420 ID - Singh2016 ER - TY - STD TI - Bhattacharya I, Pawlak S, Marraffino S, Christensen J, Sherlock SP, Alvey C, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of domagrozumab (PF-06252616), an antimyostatin monoclonal antibody, in healthy subjects. Clin Pharmacol Drug Dev. 2017 doi: https://doi.org/10.1002/cpdd.1386. ID - ref32 ER - TY - JOUR AU - Garber, K. PY - 2016 DA - 2016// TI - No longer going to waste JO - Nat Biotechnol VL - 34 UR - https://doi.org/10.1038/nbt.3557 DO - 10.1038/nbt.3557 ID - Garber2016 ER - TY - JOUR AU - Murphy, K. T. AU - Ryall, J. G. AU - Snell, S. M. AU - Nair, L. AU - Koopman, R. AU - Krasney, P. A. PY - 2010 DA - 2010// TI - Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice JO - Am J Pathol VL - 176 UR - https://doi.org/10.2353/ajpath.2010.090932 DO - 10.2353/ajpath.2010.090932 ID - Murphy2010 ER - TY - JOUR AU - Burch, P. M. AU - Pogoryelova, O. AU - Palandra, J. AU - Goldstein, R. AU - Bennett, D. AU - Fitz, L. PY - 2017 DA - 2017// TI - Reduced serum myostatin concentrations associated with genetic muscle disease progression JO - J Neurol VL - 264 UR - https://doi.org/10.1007/s00415-016-8379-6 DO - 10.1007/s00415-016-8379-6 ID - Burch2017 ER - TY - STD TI - Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, et al. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures. Skelet Muscle. 2016;6:14. ID - ref36 ER - TY - JOUR AU - Bish, L. T. AU - Sleeper, M. M. AU - Forbes, S. C. AU - Morine, K. J. AU - Reynolds, C. AU - Singletary, G. E. PY - 2011 DA - 2011// TI - Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy JO - Hum Gene Ther VL - 22 UR - https://doi.org/10.1089/hum.2011.102 DO - 10.1089/hum.2011.102 ID - Bish2011 ER - TY - JOUR AU - Argyle, D. J. AU - Nasir, L. PY - 2003 DA - 2003// TI - Telomerase: a potential diagnostic and therapeutic tool in canine oncology JO - Vet Pathol VL - 40 UR - https://doi.org/10.1354/vp.40-1-1 DO - 10.1354/vp.40-1-1 ID - Argyle2003 ER - TY - JOUR AU - Qiao, C. AU - Li, J. AU - Zheng, H. AU - Bogan, J. AU - Yuan, Z. AU - Zhang, C. PY - 2009 DA - 2009// TI - Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth JO - Hum Gene Ther VL - 20 UR - https://doi.org/10.1089/hum.2008.135 DO - 10.1089/hum.2008.135 ID - Qiao2009 ER -